• Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022

    المصدر: Nasdaq GlobeNewswire / 21 يوليو 2022 07:00:00   America/New_York

    LONDON, July 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2022 financial results and operational highlights before open of U.S. markets on Thursday, August 4, 2022.

    Management will host a conference call and webcast at 8:30 am ET/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

    A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

    Contact:

    Olivia Manser
    +44 (0) 7780 471568
    o.manser@autolus.com
    Julia Wilson
    +44 (0) 7818 430877
    j.wilson@autolus.com

    Susan A. Noonan
    S.A. Noonan Communications
    +1-917-513-5303
    susan@sanoonan.com


     


    Primary Logo

شارك على،